The role of interleukin‐1α in the pathogenesis of periapical bone destruction in a rat model system
- 1 February 1993
- journal article
- Published by Wiley in Oral Microbiology and Immunology
- Vol. 8 (1) , 50-56
- https://doi.org/10.1111/j.1399-302x.1993.tb00543.x
Abstract
To identify the mediators that stimulate periapical bone resorption following infection, a rat model system was used in which active (rapid) and chronic (slow) phases of bone destruction can be distinguished. Extracts of inflammatory tissues from active lesions contained high levels of bone‐resorbing activity, which was destroyed by proteinase K and heat (70°C), but was unaffected by polymyxin B, indicating the presence of protein mediator(s) rather than lipopolysaccharide. Fast‐performance liquid chromatography gel filtration of extracts of active lesions demonstrated that most activity was associated with macromolecules of MW 30–60 kDa and 15–20 kDa, consistent with bone resorptive cytokines, including interleukin 1 (IL‐I) and tumor necrosis factor (TNF). Inhibition with cytokine‐specific antisera demonstrated that resorbing activity in active lesions was significantly neutralized by anti‐IL‐1β, whereas anti‐IL‐1/α, anti‐TNFα and anti‐TNFα had only slight effect. A lower amount of resorbing activity was present in extracts of chronic lesions, which was also neutralized only by anti‐IL‐1α. Inflammatory tissue explants produced more IL‐1α than 1L‐1βin vitro, confirming findings with extracts, and high levels of IL‐1α were present in active lesions by radioimmunoassay. These data indicate that bone resorption stimulated by bacterial infection is primarily mediated by IL‐1α in this model. The similarity of cytokines in active and chronic lesions suggests that quantitative rather than qualitative differences in these mediators may account for lesion progression.Keywords
This publication has 48 references indexed in Scilit:
- Tissue Levels of Bone Resorptive Cytokines in Periodontal DiseaseThe Journal of Periodontology, 1991
- Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariaeJournal of Bone and Mineral Research, 1991
- Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.Journal of Clinical Investigation, 1990
- Differences in the synthesis and kinetics of release of interleukin 1α, interleukin 1β and tumor necrosis factor from human mononuclear cellsEuropean Journal of Immunology, 1989
- Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.The Journal of Experimental Medicine, 1989
- Cellular Biology and Biochemical Mechanism of Bone ResorptionClinical Orthopaedics and Related Research, 1988
- Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1.The Journal of Experimental Medicine, 1986
- Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferationCellular Immunology, 1981
- Effect of Indomethacin on Fracture Healing in RatsActa Orthopaedica, 1976
- Effects of lipopolysaccharides on bone resorption in tissue cultureCalcified Tissue International, 1972